-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) Misses Q3 EPS by 7c ; Offers Guidance
-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) PT Lowered to $96 at RBC Capital
-
-
-
-
-
-
-
Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
-
-
-
-
-
-
-
Intra-Cellular Therapies to Host Second Quarter 2023 Financial Results Conference Call and Webcast
-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 24c
-
-
-
-
-
-
-
Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 14c
-
-
-
-
-
-
-
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

